The Therapeutic Goods Administrator (TGA) has launched a website hub for transvaginal mesh information. Transvaginal mesh is used to treat pelvic organ prolapse and stress urinary incontinence. Some women have experienced serious complications from transvaginal mesh implants, and this has had a major impact on their lives. The web hub links to information on consumer support services, adverse event reporting, regulatory changes, the Senate Inquiry into transvaginal mesh, and other topics. For more information, please contact the TGA at This email address is being protected from spambots. You need JavaScript enabled to view it. or 1800 020 563.

You can visit the website here.